FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4212971961> ?p ?o ?g. }

• W4212971961 endingPage "e220130" @default.
• W4212971961 startingPage "e220130" @default.
• W4212971961 abstract "Large cohorts of patients with active cancers and COVID-19 infection are needed to provide evidence of the association of recent cancer treatment and cancer type with COVID-19 mortality.To evaluate whether systemic anticancer treatments (SACTs), tumor subtypes, patient demographic characteristics (age and sex), and comorbidities are associated with COVID-19 mortality.The UK Coronavirus Cancer Monitoring Project (UKCCMP) is a prospective cohort study conducted at 69 UK cancer hospitals among adult patients (≥18 years) with an active cancer and a clinical diagnosis of COVID-19. Patients registered from March 18 to August 1, 2020, were included in this analysis.SACT, tumor subtype, patient demographic characteristics (eg, age, sex, body mass index, race and ethnicity, smoking history), and comorbidities were investigated.The primary end point was all-cause mortality within the primary hospitalization.Overall, 2515 of 2786 patients registered during the study period were included; 1464 (58%) were men; and the median (IQR) age was 72 (62-80) years. The mortality rate was 38% (966 patients). The data suggest an association between higher mortality in patients with hematological malignant neoplasms irrespective of recent SACT, particularly in those with acute leukemias or myelodysplastic syndrome (OR, 2.16; 95% CI, 1.30-3.60) and myeloma or plasmacytoma (OR, 1.53; 95% CI, 1.04-2.26). Lung cancer was also significantly associated with higher COVID-19-related mortality (OR, 1.58; 95% CI, 1.11-2.25). No association between higher mortality and receiving chemotherapy in the 4 weeks before COVID-19 diagnosis was observed after correcting for the crucial confounders of age, sex, and comorbidities. An association between lower mortality and receiving immunotherapy in the 4 weeks before COVID-19 diagnosis was observed (immunotherapy vs no cancer therapy: OR, 0.52; 95% CI, 0.31-0.86).The findings of this study of patients with active cancer suggest that recent SACT is not associated with inferior outcomes from COVID-19 infection. This has relevance for the care of patients with cancer requiring treatment, particularly in countries experiencing an increase in COVID-19 case numbers. Important differences in outcomes among patients with hematological and lung cancers were observed." @default.
• W4212971961 created "2022-02-24" @default.
• W4212971961 creator A5003951535 @default.
• W4212971961 creator A5004362214 @default.
• W4212971961 creator A5004647151 @default.
• W4212971961 creator A5005335753 @default.
• W4212971961 creator A5014930145 @default.
• W4212971961 creator A5016382034 @default.
• W4212971961 creator A5020178573 @default.
• W4212971961 creator A5021965002 @default.
• W4212971961 creator A5023038467 @default.
• W4212971961 creator A5039547041 @default.
• W4212971961 creator A5045018770 @default.
• W4212971961 creator A5047109740 @default.
• W4212971961 creator A5052274672 @default.
• W4212971961 creator A5061454093 @default.
• W4212971961 creator A5070458650 @default.
• W4212971961 creator A5075355104 @default.
• W4212971961 creator A5080131386 @default.
• W4212971961 creator A5084069426 @default.
• W4212971961 creator A5090750138 @default.
• W4212971961 creator A9999999999 @default.
• W4212971961 date "2022-02-21" @default.
• W4212971961 modified "2023-10-16" @default.
• W4212971961 title "Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19" @default.
• W4212971961 cites W2093274439 @default.
• W4212971961 cites W2104548316 @default.
• W4212971961 cites W2599076725 @default.
• W4212971961 cites W2785424195 @default.
• W4212971961 cites W2944434778 @default.
• W4212971961 cites W2948854900 @default.
• W4212971961 cites W3006355661 @default.
• W4212971961 cites W3008443627 @default.
• W4212971961 cites W3010344953 @default.
• W4212971961 cites W3012860910 @default.
• W4212971961 cites W3024048796 @default.
• W4212971961 cites W3024270013 @default.
• W4212971961 cites W3028409757 @default.
• W4212971961 cites W3028965239 @default.
• W4212971961 cites W3030573714 @default.
• W4212971961 cites W3034965161 @default.
• W4212971961 cites W3044322186 @default.
• W4212971961 cites W3046101830 @default.
• W4212971961 cites W3047144258 @default.
• W4212971961 cites W3080162924 @default.
• W4212971961 cites W3087927078 @default.
• W4212971961 cites W3096689004 @default.
• W4212971961 cites W3120915765 @default.
• W4212971961 cites W3123544697 @default.
• W4212971961 cites W3136076419 @default.
• W4212971961 cites W4213097104 @default.
• W4212971961 cites W4294116629 @default.
• W4212971961 doi "https://doi.org/10.1001/jamanetworkopen.2022.0130" @default.
• W4212971961 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35188551" @default.
• W4212971961 hasPublicationYear "2022" @default.
• W4212971961 type Work @default.
• W4212971961 citedByCount "27" @default.
• W4212971961 countsByYear W42129719612021 @default.
• W4212971961 countsByYear W42129719612022 @default.
• W4212971961 countsByYear W42129719612023 @default.
• W4212971961 crossrefType "journal-article" @default.
• W4212971961 hasAuthorship W4212971961A5003951535 @default.
• W4212971961 hasAuthorship W4212971961A5004362214 @default.
• W4212971961 hasAuthorship W4212971961A5004647151 @default.
• W4212971961 hasAuthorship W4212971961A5005335753 @default.
• W4212971961 hasAuthorship W4212971961A5014930145 @default.
• W4212971961 hasAuthorship W4212971961A5016382034 @default.
• W4212971961 hasAuthorship W4212971961A5020178573 @default.
• W4212971961 hasAuthorship W4212971961A5021965002 @default.
• W4212971961 hasAuthorship W4212971961A5023038467 @default.
• W4212971961 hasAuthorship W4212971961A5039547041 @default.
• W4212971961 hasAuthorship W4212971961A5045018770 @default.
• W4212971961 hasAuthorship W4212971961A5047109740 @default.
• W4212971961 hasAuthorship W4212971961A5052274672 @default.
• W4212971961 hasAuthorship W4212971961A5061454093 @default.
• W4212971961 hasAuthorship W4212971961A5070458650 @default.
• W4212971961 hasAuthorship W4212971961A5075355104 @default.
• W4212971961 hasAuthorship W4212971961A5080131386 @default.
• W4212971961 hasAuthorship W4212971961A5084069426 @default.
• W4212971961 hasAuthorship W4212971961A5090750138 @default.
• W4212971961 hasAuthorship W4212971961A9999999999 @default.
• W4212971961 hasBestOaLocation W42129719611 @default.
• W4212971961 hasConcept C121608353 @default.
• W4212971961 hasConcept C126322002 @default.
• W4212971961 hasConcept C179755657 @default.
• W4212971961 hasConcept C188816634 @default.
• W4212971961 hasConcept C2776256026 @default.
• W4212971961 hasConcept C2776364478 @default.
• W4212971961 hasConcept C2779159551 @default.
• W4212971961 hasConcept C71924100 @default.
• W4212971961 hasConcept C72563966 @default.
• W4212971961 hasConceptScore W4212971961C121608353 @default.
• W4212971961 hasConceptScore W4212971961C126322002 @default.
• W4212971961 hasConceptScore W4212971961C179755657 @default.
• W4212971961 hasConceptScore W4212971961C188816634 @default.
• W4212971961 hasConceptScore W4212971961C2776256026 @default.
• W4212971961 hasConceptScore W4212971961C2776364478 @default.
• W4212971961 hasConceptScore W4212971961C2779159551 @default.

• next